Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| WVE | Wave Life Sciences | $5.47 | -$6.83 | -55.53% | 845.4K | $2.3B | $5.04$21.73 |
| ARTL | Artelo Biosciences | $3.16 | -$1.69 | -34.84% | 1.1M | $3.4M | $2.96$85.80 |
| CBUS | Cibus | $2.12 | -$0.75 | -26.13% | 10.9K | $199M | $1.09$4.19 |
| MLKN | MillerKnoll | $14.93 | -$4.43 | -22.88% | 55.6K | $1.3B | $13.77$23.18 |
| XYF | X Financial | $3.71 | -$0.91 | -19.70% | 4.5K | $118M | $3.71$20.36 |
| DERM | Journey Medical | $5.50 | -$1.33 | -19.47% | 590K | $227M | $5.45$9.56 |
| APPX | Investment Managers Series Trust II - Tradr 2x Long App Daily ETF | $27.51 | -$6.16 | -18.30% | 841.8K | - | $20.21$157.62 |
| WS | Worthington Steel | $29.24 | -$5.77 | -16.48% | 9.4K | $1.8B | $21.30$49.17 |
| CIFG | Themes ETF Trust - Leverage Shares 2x Long Cifr Daily ETF | $6.66 | -$1.28 | -16.08% | 113.8K | - | $5.46$16.08 |
| BEG | Themes ETF Trust - Leverage Shares 2x Long Be Daily ETF | $25.68 | -$4.76 | -15.65% | 11.2K | - | $10.89$50.61 |
| FEED | ENvue Medical | $2.24 | -$0.40 | -15.18% | 1.7M | $2.9M | $0.99$162.50 |
| ADMA | Adma Biologics | $8.17 | -$1.46 | -15.16% | 736.4K | $2.3B | $7.23$25.67 |
| RCAX | Tidal Trust II - Defiance Daily Target 2x Long Rcat ETF | $18.39 | -$3.00 | -14.04% | 103.7K | - | $11.66$31.62 |
| IREG | Themes ETF Trust - Leverage Shares 2x Long Iren Daily ETF | $12.62 | -$1.91 | -13.17% | 96.5K | - | $11.23$41.60 |
| RDTL | GraniteShares ETF Trust - GraniteShares 2x Long Rddt Daily ETF | $14.07 | -$2.11 | -13.04% | 461.4K | - | $9.72$89.84 |
| RKLX | Tidal Trust II - Defiance Daily Target 2x Long Rklb ETF | $29.83 | -$4.45 | -12.98% | 1.3M | - | $3.32$78.00 |
| SMCX | Tidal Trust II - Defiance Daily Target 2x Long Smci ETF | $8.56 | -$1.23 | -12.56% | 2.4M | - | $6.48$145.21 |
| UGRO | Urban-gro | $33.22 | -$3.07 | -8.46% | 6.1M | $27M | $2.02$37.00 |
| TASK | TaskUs | $6.77 | -$0.06 | -0.88% | 540.8K | $619M | $6.22$11.99 |
| DNNG | Themes ETF Trust - Leverage Shares 2x Long Dnn Daily ETF | $11.35 | $0.39 | 3.53% | 180 | - | $9.75$18.22 |
Related Articles
Featured Article
1 Brand-New Big Reason to Buy This Biotech Stock Right Now
Alex Carchidi|Oct 24, 2024
This stock currently has a good balance of risk and potential rewards.
Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics
Alex Carchidi|Oct 3, 2024
These two could become direct competitors relatively soon.
2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss
Alex Carchidi|Sep 19, 2023
The gene-editing market is moving fast, and it pays to get to know some of these companies.
Herman Miller Survives a Stress Test
Asit Sharma, CPA|Sep 19, 2020
A surge in stock price reflects investors' enthusiasm over the company's adaptability, as well as its business transformation efforts.
3 Stocks to Avoid This Week
Rick Munarriz|Sep 14, 2020
An office furniture icon, an electric vehicle upstart, and an interrupted cruise line seem pretty vulnerable.
Is ADMA Biologics a Good Coronavirus Stock to Buy Now?
Cory Renauer|Aug 25, 2020
Shares of ADMA Biologics are on the move following the FDA's authorization of convalescent plasma for the treatment of COVID-19 patients.
What You Need to Know About the "Breakthrough" Coronavirus Therapy Heralded by President Trump
Keith Speights|Aug 25, 2020
Convalescent plasma holds promise for treating COVID-19, but it's still unproven.
Why ADMA Biologics, iBio, and Kamada Are Jumping Today
George Budwell, PhD|Aug 24, 2020
The FDA's emergency use authorization of convalescent plasma therapy is sending these three stocks higher today.
Herman Miller Withdraws Earnings Guidance While Emphasizing Its Strong Balance Sheet
Asit Sharma, CPA|Mar 19, 2020
In its latest earnings report, the company provided investors with calming perspective on its staying power.
Herman Miller's Revenue Curbs on Slowing Orders
Asit Sharma, CPA|Dec 19, 2019
After several quarters of consistent strength, volatility returned to the company's order flow.
